Petition of the day
By Kate Howard
on Oct 19, 2016
Thepetition of the day is:
16-360
Issue:Whether the mere filing of an abbreviated new drug application by a generic pharmaceutical manufacturer is sufficient to subject the manufacturer to specific personal jurisdiction in any state where it might someday market the drug.
Posted in Cases in the Pipeline
Cases: Mylan Pharmaceuticals Inc. v. Acorda Therapeutics Inc.
Recommended Citation:
Kate Howard,
Petition of the day,
SCOTUSblog (Oct. 19, 2016, 12:00 AM),
https://www.scotusblog.com/2016/10/petition-of-the-day-1014/